Cannabis continues to be a successful medical alternative for many patients around the world. According to a research made by two medical teams, from the Virginia State and Florida Center universities, consuming cannabis-based products with high THC content regularly could drastically improve the immune system of HIV patients, improving the quality of their life.
Cannabis has been used by Human Immunodeficiency Virus (HIV) patients for some time. For example, to combat the side effects of pharmaceutical drugs, to combat weight loss by promoting appetite, or to combat pain.
However, research also showed that the use of THC can significantly strengthen the immune system of patients with Human Immunodeficiency Virus (HIV). That could reduce significantly the number of complications these patients can suffer and give them a much better quality of life.
If you want to know more about cannabis, how the use of cannabis-based products with THC can boost the immune system of Human Immunodeficiency Virus (HIV) patients, how this research could bring to light the many medical benefits of cannabis, and to find out the latest cannabis news, download the Hemp.im mobile application.
HIV patients who test positive for cannabis use have higher numbers of CD4 + and CD8 + cells, compared to patients who have not previously used cannabis regularly. That is shown from research results published in the journal Drug and Alcohol Dependence a couple of weeks ago. These CD4 + and CD8 + cells are a subtype of the white blood cells that support the immune system – also known as lymphocytes or T cells.
The research team from the Virginia State and Florida Center universities evaluated the differences in lymphocyte levels among two groups of HIV patients for this study. One group whose urinalysis indicated that the patient had used cannabis regularly in the past; and one group of patients who tested negative for delta-9-tetrahydrocannabinol (THC).
“After excluding demographic and HIV-related confounding factors, THC-positive patients appear to have significantly higher CD4 + and CD8 + levels than their THC-negative counterparts,” the study authors wrote. These findings are in line with previous research when it was proven that daily cannabis users have higher CD4 + cell levels and lower virus load than their non- or sporadically using counterparts.
The researchers concluded: ‘This preliminary study shows that THC-positive patients have better HIV-related immune levels than their THC-negative counterparts, despite the similarity in different demographic and Human Immunodeficiency Virus related factors. The current findings suggest a potentially useful role for cannabis in the treatment of HIV, in addition to treating symptoms.’
After all, cannabis is more often used successfully for HIV, where it contributes to the treatment of the disease in several ways. Not least to dampen the side effects of HIV inhibitors, as is the case with the Dutch HIV patient Rudolf Hillebrand. Rudolf grows his own cannabis plants to cope with the side effects of pharmaceutical drugs. Earlier, he was therefore expelled from home, but the judge has ruled that Rudolf may continue to live at home and grow 51 cannabis plants there, in his house.
Other Human Immunodeficiency Virus (HIV) patients, such as Henry, have even been able to halve their drug use thanks to the use of medical cannabis. This may be due to the immune-boosting effect of the cannabis used, which means that fewer HIV inhibitors are needed.
__
(Featured image by Anna Shvets via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Mediwietsite, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…
A new California Department of Public Health report has come out with recommendations for THC…
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…